CELGENE CORP (13)

Browse by Contract Category

Contracts

Assignment, Assumption and Amendment Agreement, dated as of November 20, 2019, among Bristol-Myers Squibb Company, Celgene Corporation, American Stock Transfer & Trust Company,... (Filed With SEC on November 20, 2019)
Form of Contingent Value Rights Agreement by and between Bristol-Myers Squibb Company and [Trustee] (Filed With SEC on January 4, 2019)
Celgene Corporation Executive Severance Plan (Filed With SEC on January 4, 2019)
Agreement and Plan of Merger by and among Bristol-Myers Squibb Company, Burgundy Merger Sub, Inc. and Celgene Corporation, dated as of January 2, 2019 (Filed With SEC on January 4, 2019)
Asset Purchase Agreement dated August 25, 2019, by and between Celgene Corporation, as seller, and Amgen Inc., as purchaser (Filed With SEC on August 26, 2019)
First Supplemental Indenture, dated May 1, 2019, to Indenture, dated October 7, 2010 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,... (Filed With SEC on July 30, 2019)
First Supplemental Indenture, dated May 1, 2019, to Indenture, dated August 9, 2012 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,... (Filed With SEC on July 30, 2019)
First Supplemental Indenture, dated May 1, 2019, to Indenture, dated August 6, 2013 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,... (Filed With SEC on July 30, 2019)
First Supplemental Indenture, dated May 1, 2019, to Indenture, dated May 15, 2014 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,... (Filed With SEC on July 30, 2019)
First Supplemental Indenture, dated May 1, 2019, to Indenture, dated August 12, 2015 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,... (Filed With SEC on July 30, 2019)
First Supplemental Indenture, dated May 1, 2019, to Indenture, dated August 10, 2017 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,... (Filed With SEC on July 30, 2019)
First Supplemental Indenture, dated May 1, 2019, to Indenture, dated November 9, 2017 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,... (Filed With SEC on July 30, 2019)
First Supplemental Indenture, dated May 1, 2019, to Indenture, dated February 20, 2018 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust... (Filed With SEC on July 30, 2019)